Executive Committee

Peter Bains has over three decades of experience in the pharmaceutical and biotechnology sectors. At Syngene, he is responsible for strategy and execution, steering investment decisions, leading the executive team and the Company's business operations.

Bains has extensive global experience in strategic and operational leadership, including at the board, CEO and senior corporate leadership levels. He has an extensive track record of success in building companies, businesses, teams and brands. His experience in biopharmaceuticals straddles business and technology segments (biotechnology, vaccines, branded generics, life sciences, CRO) and geographies encompassing both advanced and emerging markets.

He served as CEO of Sosei Group (now Nxera Pharma), a Japanese listed biopharmaceutical company. Prior to this, he worked with GlaxoSmithKline for 23 years, where he held several roles, including Head of Global Marketing and Senior Vice President of commercial development for GSK's international regions. He also served as CEO and on the board of Syngene for almost six years from 2010 and led the Company to its successful public listing in 2015.

He holds a bachelor's degree in science (combined honors in Zoology and Physiology) from the University of Sheffield, UK.

Abhijit Zutshi brings 27 years of diverse commercial experience in the pharmaceutical industry, with deep expertise across B2B and B2C environments spanning both drug substances and drug products, as well as small and large molecules.

Zutshi spent nearly 25 years at Biocon, where he built a distinguished career across sales, marketing, business development, asset acquisition, portfolio management and market entry strategy. In 2006, he relocated to the United States to lead North American operations. Most recently, serving as Chief Commercial Officer for Biocon's generics business, he oversaw both the drug substance and drug product divisions and spearheaded the creation of a global team dedicated to the generic formulations business.

Prior to Biocon, Zutshi was a Product Specialist at Pfizer (formerly Wyeth Lederle), where he successfully launched the Zosyn brand in India.

A licensed pharmacist and MBA graduate, he further sharpened his leadership acumen through the Leadership Development executive education program at Harvard Business School.

Ajay Tandon's core competencies include market management, business planning, strategic thinking, relationship building and risk assessment. These skills have consistently enabled him to drive strong growth momentum through the expansion of existing relationships and the strategic acquisition of new clients.

Tandon holds a Postgraduate Diploma in Management from the Indian Institute of Management, Ahmedabad and a Bachelor of Engineering in Electrical Engineering from the Delhi College of Engineering.

Alok Mehrotra holds an M.Tech. in Chemical Technology (Food Technology) from Harcourt Butler Technological Institute. He has more than 25 years of experience spanning manufacturing operations, quality assurance, sustainability/EHS, production and supplier technical assurance across varied industries.

Over the years, Mehrotra has worked with leading corporates, including Dr. Reddy's, Reckitt Benckiser, Pepsi Foods Ltd and Godrej Foods and Beverages Ltd. In his recent assignment as Head of Global Quality Management at Dr. Reddy's, he harmonized and integrated Quality management systems globally and was also responsible for quality across all external suppliers and vendors. As the Chief Quality, Engineering and Safety Officer (CQESO), he leads the Quality and Compliance function while also managing Syngene's extensive infrastructure, encompassing the Company's facilities and assets.

Deepak Jain oversees finance, supply chain, legal and secretarial functions and plays an important role in driving strategy, improving profitability, identifying new opportunities, improving cash generation and enabling organizational growth.

Jain was previously with Ather Energy, where he led the company to significant revenue growth over four years as the Chief Financial Officer. Prior to that he was the India CFO for First Advantage and for Apple, where he was part of the team that led to Apple's expansion in the Indian market. He has also held leadership roles at Procter & Gamble and started his career at Ernst & Young India.

He has over 25 years of experience managing multi-location operations and transactional revenues. He has successfully led business growth strategies across different industries and is skilled in process engineering, distribution modeling, sales finance, tax compliance and finance controlling across various regions and organizational structures.

He is a Chartered Accountant with a Bachelor of Commerce degree from Calcutta University.

Gaurav Kushwaha leads the development and execution of the Company's AI and digital transformation strategy, driving smarter, faster and scalable operations across the entire value chain.

Kushwaha brings over 24 years of rich experience in IT and digital transformation across diverse industries, including telecom, banking, defense, pharmaceuticals and manufacturing. He has consistently leveraged technology to drive strategic business outcomes, delivering significant EBITDA impact and operational efficiencies. He holds certifications in Six Sigma, TOGAF and ISO 27001/38500 and has completed executive programs in digital leadership from INSEAD and ISB.

Jayashree Aiyar has over 30 years of experience as a molecular pharmacologist and has led drug discovery programs in global organizations in the USA, such as AstraZeneca, Merck, Ambrx and Theravance, and at Jubilant Biosys in India. Dr. Aiyar has more than 30 peer-reviewed publications and book chapters to her credit and two issued patents.

She joined Syngene in 2016 to lead the Discovery Biology function, which has grown significantly under her leadership. In her role as Chief Scientific Officer, she plays a pivotal role in driving the Company's scientific strategy and innovation in R&D as well as strengthening academic and industry collaborations, ensuring that Syngene continues to lead with cutting-edge solutions for its clients.

She holds a PhD in Immunology from the All India Institute of Medical Sciences, New Delhi and completed post-doctoral research at the California Institute of Technology and the University of California, Irvine.

Maninder Kapoor Puri oversees the Human Resources function at Syngene, leading the Company's global people agenda across talent strategy, organizational development, leadership capability, culture and digital HR ecosystems. As a member of the Executive Committee, she plays a key role in aligning people strategy with business priorities and enabling Syngene's next phase of growth.

Puri brings nearly three decades of experience driving business transformation through people, leadership and culture across global organizations. She is known to partner closely with CEOs, Boards and leadership teams to lead large-scale, multi-market transformations across North America, EMEA and APAC, building agile, high-performance organizations aligned to business outcomes.

Her cross-industry experience spans biopharmaceuticals, IT services, and consulting, with deep expertize across organizational design, leadership development, talent and succession, performance and rewards, employee engagement, DEIB and CSR, people analytics, strategic communication, and digital HR ecosystems.

Puri joined Syngene from Biocon, where she served as CHRO, leading enterprise-wide culture and leadership transformation. Prior to this, she served as Global CHRO at Mastek, leading HR across 40+ countries and playing a key role in scaling the organization. She has also held senior leadership roles at Accenture and Firstsource Solutions, driving HR strategy across diverse markets.

She has been featured by Outlook Business as a face of "Viksit Bharat" and recognized among HR Today's Top 100 Global CHROs, India's Most Agile Leaders (2026), and as CHRO of the Year. A recognized thought leader and strong voice shaping the future of work and talent transformation, she contributes actively to global HR and leadership discourse. She also serves as a Governing Body Member at the Life Sciences Sector Skill Development Council (LSSSDC), contributing to industry capability building.

Mrinal Kammili is Head of Translational and Clinical Research. As an Executive Committee member, he is responsible for driving strategy, growth, and execution across global programs.

He has nearly 30 years of experience across healthcare delivery, pharmaceuticals, clinical research, and life science with a strong track record in scaling global operations, building high-performing organizations, and leading strategic initiatives across business development, corporate strategy, M&A, and transformation. He has previously served as Executive Director and Board Member for organizations headquartered in the United States and India, with responsibility for global operations, market expansion, and organizational transformation.

A medical doctor with a background in cardiology and intensive care, he brings a distinctive clinical and business perspective. He is currently pursuing advanced training in Healthcare Management at the Indian School of Business (ISB) and serves as Chairperson of the Institutional Animal Ethics Committee.

Pramuch Goel has completed the Global Program for Management Development from the Ross School of Business at the University of Michigan. He holds an MBA from the Birla Institute of Management Technology, New Delhi and a degree in English (Hons) from the University of Delhi. He also possesses certifications in digital marketing and a PGDM in public relations.

Goel joined Syngene in August 2024 from the Mahindra Group, where he served as Vice President and Head of Group Communications. Prior to Mahindra, he held positions at companies including Samsung India, Cisco Systems, IBM India and Quark Inc. As a member of the Executive Committee and the ESG Council, his responsibilities encompass corporate communications, public affairs and ESG activities.

Priyaranjan Pattanaik is a seasoned scientist and business leader with over 23 years of experience in the pharmaceutical and biotech sectors, particularly in the CRO/CDMO space. With deep expertise in biotherapeutics, including antibodies, bispecifics, ADCs, peptides, proteins and cell and gene therapies, he has successfully taken forward programs from early discovery to clinical development. He is also a passionate mentor and champion of talent development and innovation.

He holds a PhD in Structural Biology from JNCASR, Bengaluru and completed his postdoctoral research in structure-based drug discovery at Case Western Reserve University, USA.

Rohtash Kumar is an established pharmaceutical operations leader with over two decades of experience in R&D, manufacturing and executive leadership across global CDMO organizations. His career includes significant roles at renowned companies such as Bachem Americas, Sigma-Aldrich and Apotex. Most recently, he led Global Technology and Development at Veranova, where he drove innovation in APIs, including small molecule, peptides, oligonucleotides and biologics. His efforts successfully advanced branded API molecules to market in collaboration with biotech partners, showcasing his ability to bridge the gap between research and commercialization.

A prolific researcher, he holds multiple patents and publications to his credit. He earned his Ph.D. in Organic Chemistry from the University of Delhi, an M.Sc. in Organic Chemistry and an MBA from Chaudhary Charan Singh University. Additionally, he is a member of the American, Canadian and Indian Medical Societies.

Subhendu Kumar Mohanty holds a Ph.D. in Organic Chemistry from IIT Madras and completed postdoctoral research in Biophysical Sciences at the National Centre for Biological Sciences (NCBS), Bengaluru.

He is a Syngene veteran with 18 years of experience, specializing in synthetic chemistry, medicinal chemistry and drug discovery across multiple modalities, demonstrating strong leadership and collaborative skills. Throughout his career, he has contributed significantly to advancing therapeutic development and scientific innovation.

Surender Sharma brings two and a half decades of rich experience across corporate governance, mergers and acquisitions, joint ventures, compliance and regulatory affairs, having worked with leading organizations, including Colgate-Palmolive, Marico, Heinz, Indian Hotels, Reckitt and Maruti.

Throughout his career, Sharma has been recognized for his strategic counsel, commercial acumen and integrity-driven leadership. He has successfully navigated complex legal and governance landscapes, advised boards and leadership teams on risk and compliance and played a pivotal role in shaping corporate ethics and sustainability frameworks. At Syngene, he leads the Legal, Secretarial, and Regulatory Affairs functions.

Sharma holds a Bachelor of Science in Chemistry from St. Stephen's College, an LLB from Delhi University and is a qualified Company Secretary.